Abstract:Background Heart failure (HF) is a syndrome due to cardiac insufficiency, manifested by excessive volume overload, increased sympathetic activity, and circulatory redistribution [1]. Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 40%-50% of the total HF events, and its development is often accompanied by various complications, including hypertension, obesity, and metabolic syndrome. Biomarker associations in heart failure with reduced ejection fraction were mostly cardiac stretch based, while many biomarkers of HFpEF are also associated with inflammation [2]. To date, treatments that effectively improve the clinical prognosis of HFpEF are relatively limited, thus HFpEF remains one of the challenges that needs to be further explored. A full understanding of the molecular mechanisms of HFpEF is essential to improve the early diagnosis, treatment and prognosis of these patients. Purpose The study aims to explore key circulating miRNAs and related molecular pathways in HFpEF patients through bioinformatics analysis and machine learning, and to further validate them using a double-hit HFpEF mouse model. Methods We downloaded HF datasets including circulating miRNA expression profiles from the GEO database. LASSO regression, SVM-RFE, Random Forest and XGboost algorithm were conducted to identify key miRNAs for diagnostic model construction. We used R software, GO, KEGG and Cytoscape to better understand the functions of key miRNA targets. Besides, the mRNA-miRNA interaction networks were predicted by starbase. We also constructed a HFpEF mouse model subjected to high fat diet and L-NAME (0.5 g/L) in drinking water to discover the correlation between the screened circulating miRNA and HFpEF. Results After differential expression analysis of the combined HFpEF dataset, we identified 37 differentially circulating miRNAs, of which 15 were down-regulated and 22 were up-regulated. Subsequently, we screened by machine learning and identified 4 key miRNAs that may be involved in the progression of HFpEF, including hsa-miR-645, hsa-miR-296-5p, hsa-miR-199b-5p, and hsa-miR-509-3-5p. We validated these miRNAs based on their expression, and the ROC plots suggest that these miRNAs may have diagnostic capability in HFpEF. The results of GO and KEGG enrichment analyses showed that the target genes of the differentiated miRNAs were mainly enriched in the MAPK signaling pathway, mTOR signaling pathway, protein processing in endoplasmic reticulum, hippo signaling pathway, cell cycle, Foxo signaling pathway, hypertrophic cardiomyopathy, dilated cardiomyopathy, and circadian rhythm. The mRNA-miRNA interaction networks suggested that TMEM135 was regulated by both has-miR-199b-5p and hsa-miR-296-5p. The RT-PCR results also suggested that miR-199b-5p was upregulated in the HFpEF mice. Conclusion We validated 4 circulating miRNAs with strong correlation to HFpEF, which provide a more reliable basis for pre-symptomatic diagnosis.

Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Abnormal Expression Profile of Plasma-Derived Exosomal Micrornas in Patients with Treatment-Resistant Depression

Serum Exosome-Derived Mir-139-5p As a Potential Biomarker for Major Depressive Disorder

Exosomal let-7e, miR-21-5p, miR-145, miR-146a and miR-155 in Predicting Antidepressants Response in Patients with Major Depressive Disorder

Exosomal miRNAs in patients with chronic heart failure and hyperuricemia and the underlying mechanisms

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction

Screening of Secretory Proteins Linking Major Depressive Disorder with Heart Failure Based on Comprehensive Bioinformatics Analysis and Machine Learning

Expression profiles and potential functions of microRNAs in heart failure patients from the Uyghur population

Diagnostic potential of a circulating miRNA model associated with therapeutic effect in heart failure

Exosomes from Patients with Major Depression Cause Depressive-Like Behaviors in Mice with Involvement of Mir-139-5p-regulated Neurogenesis.

Exosomal miR-1202 mediates Brodmann Area 44 functional connectivity changes in medication-free patients with major depressive disorder: An fMRI study

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study

Differentially Expressed Mirnas in Circulating Exosomes Between Atrial Fibrillation and Sinus Rhythm

Serum Exosomal Microrna-146A As a Novel Diagnostic Biomarker for Acute Coronary Syndrome.

Circulating Exosomal Mirnas As Novel Biomarkers for Stable Coronary Artery Disease

Dysregulation of MicroRNAs Derived from Plasma Extracellular Vesicles in Schizoaffective Disorder

Diagnostic and prognostic value of microRNA423-5p in patients with heart failure

Abstract 13856: Circulating Microrna Differentiates HFpEF and HFrEF Patients

Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis